pathway_id,pathway_term,pathway_source,proteins
hsa04080,"Neuroactive ligand-receptor interaction",KEGG,CGA;HRH3;CHRM2;CHRM3;CHRNA5;CHRNA7;CHRNB1;ADCYAP1R1;CNR1;ADORA1;ADORA2B;ADRA1D;ADRA1B;ADRA1A;ADRA2B;ADRB1;ADRB2;ADRB3;DRD2;AGTR1;AGTR2;S1PR1;S1PR3;EDNRA;F2;F2R;F2RL1;FPR1;FPR2;FSHB;FSHR;GABBR1;GABRA5;GH1;GHR;GHSR;GLRB;GNRHR;NPBWR1;P2RY8;GRIA4;GRIN2A;NR3C1;GRM3;GRM6;GRM8;HRH1;HTR2B;HTR2C;HTR7;LEP;LEPR;LHB;LHCGR;MC2R;MC4R;MTNR1A;MTNR1B;NPY1R;NPY2R;NPY5R;OPRL1;OXTR;P2RX4;PLG;AVPR2;PRL;PRLR;PARD3;PRSS1;PRSS3;PTAFR;PTGDR;PTGER2;PTGER3;PTGER4;PTGFR;PTH2R;SSTR1;SSTR5;TSPO;THRA;C5AR1;TRPV1;KISS1R;CCKBR;GABBR2;P2RY14
WP1602,"Nicotine Activity on Dopaminergic Neurons",WikiPathways,CHRNA5;PRKACA;GNAI1;CDK5;KCNK3;GNB1;PPP1CA;DRD2;SLC18A2;TH